Evaluation of rapid tests for human immunodeficiency virus as a tool to detect recent seroconversion

Imagem de Miniatura
Arquivos
art_BARRETO_Evaluation_of_rapid_tests_for_human_immunodeficiency_virus_2012.PDF (159.89 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2012
Editora
CONTEXTO
DOI
Indexadores
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
GIRARDI, Samira Barboza
BARRETO, Angela Maria Egydio de Carvalho
PROIETTI, Anna Barbara
CARVALHO, Silvia Maia Farias de
LOUREIRO, Paula
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.16, n.5, p.452-456, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The identification of recent HIV infection is important for epidemiological studies and to monitor the epidemic. The objective of this study was to evaluate two rapid tests that are easily available to the Brazilian scientific community for using as markers of recent HIV infection. The Rapid Test - HIV-1/2 Bio-Manguinhos (Bio-Manguinhos/Fiocruz, Brazil) and the Rapid Check HIV 1&2 (NDI-UFES, Center for Infectious Diseases, Universidade Federal do Espirito Santo) were tested, using 489 samples with HIV positive serology, from blood donors, previously classified as recent or long-term infection by serological testing algorithm for recent HIV seroconversion (STARHS) or LS-HIV Vitros assay methods. The samples were diluted prior to testing (1:50 and 1:100 for the Rapid Test - HIV-1/2 Bio-Manguinhos, and 1:500 and 1:600 for the Rapid Check HIV 1&2). Negative samples were considered recent infection, whereas those showing any color intensity were associated with long-term infection. The best dilutions were 1:100 for HIV-1/2 Bio-Manguinhos test (Kappa = 0.840; overall agreement = 0.93), and 1:500 for the Rapid Check HIV 1&2 (Kappa = 0.867; overall agreement = 0.94). The results suggest that both rapid tests can be used to detect recent seroconversion.
Palavras-chave
HIV-1 incidence, Detuned assay, Surveillance, Rapid test
URI
https://observatorio.fm.usp.br/handle/OPI/751
Referências
  1. Balasubramanian R, 2009, INTERNET BIOM SOC, V66, P1
  2. Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005
  3. Barin F, 2008, EUROSURVEILLANCE, V13, P1
  4. Barreto CC, 2005, TRANSFUSION, V45, P1709, DOI 10.1111/j.1537-2995.2005.00575.x
  5. Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142
  6. Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3
  7. Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06
  8. Constantine NT, 2005, INDIAN J MED RES, V121, P519
  9. Constantine NT, 2003, JAIDS, V32, P94
  10. Donovan BJ, 2004, ANN PHARMACOTHER, V38, P670, DOI 10.1345/aph.1D314
  11. Duarte G, 2001, REV BRASILEIRA GINEC, V23, P107, DOI 10.1590/S0100-72032001000200008
  12. Ferreira Junior Orlando C, 2005, AIDS, V19 Suppl 4, pS70, DOI 10.1097/01.aids.0000191494.51489.75
  13. Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7
  14. Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520
  15. Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555
  16. Hare CB, 2006, CLIN INFECT DIS, V42, P700, DOI 10.1086/500215
  17. Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960
  18. Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42
  19. Kassanjee R, 2011, PLOS ONE, V6, P1
  20. Keating SM, 2010, CDC APHL DIAGN C
  21. Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012
  22. Kshatriya R, 2008, J CLIN MICROBIOL, V46, P3482, DOI 10.1128/JCM.00665-08
  23. Machado DM, 2002, AIDS, V16, P113, DOI 10.1097/00002030-200201040-00014
  24. McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a
  25. Ministerio da Saude. Brasil. Secretaria de Vigilancia em Saude. Programa Nacional de DST e AIDS, 2008, REC TER ANT AD INF P
  26. Murphy G, 2008, EUROSURVEILLANCE, V13, P4
  27. Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0
  28. Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874
  29. Pillonel J, 2008, TRANSFUSION, V48, P1567, DOI 10.1111/j.1537-2995.2008.01739.x
  30. Piwowar-Manning Estelle M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P170, DOI 10.1177/1545109710368151
  31. Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349
  32. Sabino EC, 2012, TRANSFUSION, V52, P870, DOI 10.1111/j.1537-2995.2011.03344.x
  33. Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277
  34. Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343
  35. Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387
  36. Soroka SD, 2005, CLIN DIAGN LAB IMMUN, V12, P918, DOI 10.1128/CDLI.12.8.918-921.2005
  37. Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002
  38. Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012
  39. Unaids, 2009, AIDS EP UPD 2009
  40. Unaids, 2009, REL GLOB EP AIDS 200
  41. Unaids, 2011, WORLD AIDS DAY REP 2
  42. Vu SL, 2008, EUROSURVEILLANCE, V13, P11
  43. Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133
  44. Wilson KM, 2004, AIDS, V18, P2253, DOI 10.1097/00002030-200411190-00005
  45. Withum DG, 2002, INT C AIDS 14 INT AI

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - LIM/52
Artigos e Materiais de Revistas Científicas - LIM/56